General Information of Drug Metabolite (DM) (ID: DM017361) |
DM Name |
Remogliflozin etabonate metabolite M13
|
Structure |
|
3D MOL is unavailable
|
2D MOL is unavailable
|
|
|
|
|
|
|
|
Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
DME(s) Producing This DM through Metabolism |
|
|
|
|
|
|
|
Full List of Drug(s) That Produce This DM By Metabolism |
Remogliflozin etabonate |
DR3258
|
Phase 2 |
Type-1/2 diabetes |
|
References |
1 |
Assessment of the drug interaction risk for remogliflozin etabonate, a sodium-dependent glucose cotransporter-2 inhibitor: evidence from in vitro, human mass balance, and ketoconazole interaction studies
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.